COVID-19 Variant
Novavax to Seek Regulatory Approval After COVID-19 Vaccine Displays 90% Efficacy in US Trial
2021-06-15
COVID-19: Rise in UK Cases Trigger Global Concerns Over “Highly Infectious” Delta Variant
2021-06-14
Vir, GSK’s Antibody Therapy Effective Against COVID-19 Variants, Reduces Hospitalization and Deaths by 85%
2021-03-11
LATEST
NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO’s Demo Day
2023-06-07
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
EVENT
2023-06-05
Redefining Early Stage Investments (RESI) 2023 conference series – RESI Boston
Boston, USA